CTRI/2018/04/013014RecruitingPhase 1
Evaluation of the Safe Care, Saving Lives (SCSL) qualityimprovement collaborative in Telangana and Andhra Pradesh
ondon School of Hygiene and Tropical Medicime0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Pregnant women giving birth and newborn babies aged 0-27 days born or admitted in the study hospitals.
- •2.Health workers in study hospitals
- •3.Study hospitals with a SNCU/NICU which are included into the state insurance schemes (CEO Aarogyasri Health Care Trust in Telengana State; and the Dr. NTR Vaidya Seva Scheme )
Exclusion Criteria
- •1.Hospitals that are not included into the state insurance schemes (Aarogyasri Health Care Trust in Telengana State; and the Dr. NTR Vaidya Seva Scheme)
- •2.pregnant Women, and health workers who do not consent to be observed
Investigators
Similar Trials
Recruiting
Not Applicable
An observational study to evaluate safety and effectiveness of hydrophilic acrylic intraocular lens.CTRI/2021/11/037924Carl Zeiss Meditec AG
Active, not recruiting
Phase 2
Evaluating the effectiveness of bariatric surgeries: Scopinaro modified and classic Scopinaro in treating obesityC18.654.726.500obesityRBR-842vr3Instituto Paulo Reis de Clínica Cirúrgica e Obesidade Mórbida S/S
Active, not recruiting
Not Applicable
ENSAYO CLÍNICO PILOTO PARA EVALUAR LA SEGURIDAD Y EFICACIA DE CAMBIAR EL ITINAN O EL IP A MARAVIROC EN PACIENTES INFECTADOS POR EL VIH-1 CON CARGA VIRAL INDETECTABLE Y DISLIPEMIA ASOCIADA A LOS ANTIRETROVIRALES (PILOT STUDY TO ASSESS THE SAFETY AND EFICACY OF SWITCHING THE NNRTI OR PI TO MARAVIROC IN HIV-1-INFECTED SUBJECTS WITH PERSISTENT VIREMIA SUPPRESSION EXPERIENCING NNRTI OR PI-RELATED DYSLIPEMIA)EUCTR2009-011868-11-ESluita contra la Sida Foundation
Active, not recruiting
Not Applicable
Study LRS114689: A study to assess the safety, tolerability and preliminary efficacy of GSK2251052 in the treatment of complicated intra-abdominal infections in adults.complicated intra-abdominal infection in adultsMedDRA version: 14.1Level: LLTClassification code 10056570Term: Intra-abdominal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-000485-35-ITGLAXOSMITHKLINE RESEARCH & DEVELOPMENT LTD.210
Completed
Not Applicable
Assessment of safety and effectiveness: the clinical use of tofogliflozin in patients with type 2 diabetes mellitusJPRN-UMIN000014129Japan Association for Diabetes Education and Care10,000